Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Transmedics Inc. has 1 pending office action currently in its portfolio. This application is assigned to examiner WIEST, PHILIP R, who is listed as the busiest examiner with 1 pending action. With 1 distinct examiner involved, the company's prosecution efforts are concentrated on a single point of contact. The record shows 0 distinct art units, but the presence of 1 pending office action confirms that the matter is active within the examination system. This relationship between the action and the examiner facilitates a streamlined communication process.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Double-patenting only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WIEST, PHILIP R | 1 | 81.3% | +16.3% |
| MOSS, NATALIE M | 1 | 30.8% | +17.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18960493 | AORTIC CANNULA FOR EX VIVO ORGAN CARE SYSTEM | WIEST, PHILIP R | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18605672 | SYSTEMS AND METHODS FOR EX VIVO ORGAN CARE | MOSS, NATALIE M | 134d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18605672 | SYSTEMS AND METHODS FOR EX VIVO ORGAN CARE | MOSS, NATALIE M | 134d overdue |
| 18960493 | AORTIC CANNULA FOR EX VIVO ORGAN CARE SYSTEM | WIEST, PHILIP R | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18960493 | AORTIC CANNULA FOR EX VIVO ORGAN CARE SYSTEM | WIEST, PHILIP R | — | DP | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18605672 | SYSTEMS AND METHODS FOR EX VIVO ORGAN CARE | MOSS, NATALIE M | 1653 | §101§103 | Non-Final OA | 134d overdue | Pending | Mar 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial